Inhibition of Rac1 specifically in the VTA enhances IA LTM
Based on previous findings from our laboratory showing that the VTA24 and the HP25 promote active forgetting of a rewarding single-trial cocaine-place conditioning in rats, and that hippocampal Rac1 seems to play a role in active forgetting in mice,17 we first studied the effect of the inhibition of Rac1 activity in 3 selected brain regions known to be important for IA memory processing: the VTA, the HP and the amygdala (AMG).23,26 As shown in Fig. 1, the immediate post-training infusion of NSC23766 (150 ng/0.5 ul/side) into the VTA (Fig. 1b, U = 26, p = 0.0118; nVeh = 12, nNSC = 11), but not into the dorsal HP (Fig. 1c, 1d: U = 60, p > 0.9999; 7 d: U = 36, p = 0.1108; 14 d: U = 54, p = 0.6853; nVeh = nNSC = 11) or the AMG (Fig. 1d, 1d: U = 56,60, p > 0.8282; 7 d: U = 57, p = 0.8718; 14 d: U = 59, p = 0.9742; nVeh = 12, nNSC = 10), enhanced LTM 1 d after training. Furthermore, memory enhancement is maintained at 7 and 14 d tests (Fig. 1b, 7d: U = 29, p = 0.0225; 14 d: U = 31, p = 0.0310).
Does Rac1 induce an active forgetting mechanism, or down-regulate memory formation?
To determine whether the enhanced memory expression observed with Rac1 inhibition was due to protecting IA memory from forgetting rather than facilitating memory formation, we conducted two control experiments. First, we tested recent memory after the immediate post-training inhibition of Rac1 activity in the VTA. We confirmed that all animals expressed IA memory at 1 h (Fig. 2a. Veh: W = 55, p = 0.0010, nVeh = 10; NSC: W = 28, p = 0.0078, nNSC = 7) which was not modified by NSC23766 infusion (1 h: U = 34, p = 0.9623). This is consistent with the notion that Rac1 activity has no impact on memory formation in rodents.17,27,28 Second, with the aim of sensitizing the experimental protocol to allow a better visualization of a potential facilitatory effect on memory formation we used a weak foot-shock in the training session. The prediction of using a weak IA protocol is that a facilitatory effect of a given compound on memory formation should be equal to or greater than that observed when using a stronger IA protocol.26,29,30 As expected, rats subjected to a weak IA protocol showed poor memory (Fig. 2b, Veh: 1 h vs TR: W = 28, p = 0.0078, 1 d vs TR: W = 28, p = 0.0078, nVeh = 7; NSC: 1 h vs TR: W = 21, p = 0.0156, 1 d vs TR: W = 19, p = 0.0313, nNSC = 6). However, in contrast to the above mentioned prediction, the immediate post-training infusion of NSC23766 into the VTA in rats subjected to a weak IA protocol did not induce any enhancement of IA memory (Fig. 2b, 1h: U = 16, p = 0.5338; 1 d: U = 21, p > 0.9999; 7 d: U = 15, p = 0.4452).
Memory enhancement induced by Rac1 inhibition in the VTA is time-dependent
To assess whether there were other periods at which the infusion of NSC23766 into the VTA could induce memory enhancement, we infused the Rac1 inhibitor at several time points after acquisition. We first assessed the effect of the infusion of NSC23766 at 12 h after training since previous studies have shown the relevance of this time point for the persistence but not formation of aversive memories.22,23 Rac1 inhibition at this specific time did not provoke memory enhancement but instead decreased memory expression at 1 d (Fig. 3a, 1d: U = 27, p = 0.0471; 7 d: U = 28, p = 0.0593; 14 d: U = 52, p = 0.8633; nVeh = 10, nNSC = 11) ruling out the possibility that memory enhancement induced by the immediate administration of NSC23766 into the VTA (see Fig. 1b) was caused by a protracted action on memory retrieval. Also, we wondered whether a memory enhancement could be observed when Rac1 activity was inhibited immediately after retrieval since a previous work showed that manipulation of Rac1 activity in the HP at this time point improved memory expression for a contextual fear conditioning in mice.20 We first confirmed memory expression and homogeneity between groups at 1 d (Veh: W = 66, p = 0.0005; NSC: W = 45, p = 0.0020; 1 d: U = 34, p = 0.1716, nVeh = 11, nNSC = 9). Then we assessed the effect of the infusion of NSC23766 into the VTA immediately post retrieval and found no effect on IA memory expression at 7 and 14 days. (Fig. 3b, 7d: U = 39, p = 0.4453; 14 d: U = 44, p = 0.7077).
Rac1 inhibition in the VTA has no effect on locomotor activity or anxiety-like behavior
Given that anxiety-like behavior in mice is controlled by VTA projections to AMG31 and lateral septum,32 we next determined whether the inhibition of Rac1 in the VTA could induce anxiety-like behavior 1 d later (Fig. 4a). Rats infused with NSC23766 displayed similar performance to control animals in the EPM (Fig. 4b-d. (b) t(20) = 0,58, p = 0.5691. (c) t(20) = 0.46, p = 0.6515. (d) t(20) = 0.43, p = 0.6718, nveh = 12, nNSC =10) as well as in the OF task (Fig. 4e-f. (e) t(22) = 0.38, p = 0.7054. (f) t(22) = 0.86 p = 0.3989, nveh = 14, nNSC =10). These results rule out the possibility that higher latency observed from 1 d after IA training in animals infused with NSC23766 (see Fig. 1a) was driven by differences in anxiety or locomotor activity.
ERK 1/2 signaling is not involved in memory enhancement induced by Rac1 inhibition
Rac1 activates an important number of signaling pathways, including among others, those that modulate signal transduction and protein synthesis regulated by MEK1/2/ERK1/2 pathway.33–35 In addition, ERK 1/2 modulates forgetting of a transient aversive memory in Drosophila.9,18 Therefore, we infused the selective MEK1/2 inhibitor U0126 (0.25 µg/0.5 µl/side) into the VTA, a dose that consistently affects memory formation and persistence in rats.24,36 No effect on memory retention scores was found at any time point tested (Fig. 5, 1d: U = 39, p = 0.6513; 7 d: U = 42, p = 0.8416; 14 d: U = 37, p = 0.5481; nVeh = 9, nNSC = 10).